Powered by Studio M | 1917 Concourse Dr. San Jose CA 95131

  • NEWS DESK

BAYER FACES FOURTH U.S. ROUNDUP CANCER TRIAL


(Reuters) - Bayer AG (BAYGn.DE) is set to face a fourth U.S. jury trial over allegations that its Roundup weed killer causes cancer, with four cancer patients in the hometown of its agricultural subsidiary Monsanto scheduled to begin making their case on Friday.

The lawsuit marks the first multi-plaintiff trial in the litigation over whether glyphosate, Roundup’s active ingredient, is carcinogenic, and is the first trial outside of California. It is being held in St. Louis, where Monsanto was headquartered before Bayer bought the company in a $63 billion deal in 2018.


Read More

amazon smile for pragnya.png
Our Non- Profit Partners
pragnya_logo.png
RDH_listen_live.png
LOCAL EVENTS
BAY AREA NEWS